ResMed Inc. RMD Income Statement

Resmed inc. (RMD)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09
Net revenue
769,455	736,157	681,100	704,944	662,228	651,100	588,300	623,630	591,634	601,273	523,659	556,686	514,204	530,397	465,450	518,647	453,879	454,540	411,647	453,064	422,497	422,952	380,399	415,212	397,758	384,341	357,662	414,608	383,581	376,537	339,731	371,930	349,073	332,738	314,774	341,892	313,258	305,986	282,012	291,572	278,659	275,134	246,992
Cost of sales (exclusive of amortization shown separately below)
307,657	296,975	-	-	270,318	267,369	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition related expenses (note 21)
-	-	-	-	-	-	-	-	-	-	-	-	-	10,076	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Donations to research foundations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1,000	0	1,000	1,000	1,000
Total cost of sales
319,793	309,027	276,001	266,975	281,258	276,568	245,186	261,158	247,339	251,481	218,054	232,910	214,490	221,326	196,266	217,158	193,999	188,031	173,028	193,634	171,066	159,730	143,086	153,955	145,970	135,582	129,680	154,760	144,132	143,825	131,083	145,460	138,577	134,023	129,720	143,022	130,755	119,987	108,058	117,055	112,076	110,929	96,814
Gross profit
449,662	427,130	405,055	437,990	380,970	374,532	343,093	362,472	344,295	349,792	305,605	323,776	299,714	309,071	269,184	301,489	259,880	266,509	238,619	259,430	251,431	263,222	237,313	261,257	251,788	248,759	227,982	259,848	239,449	232,712	208,648	226,470	210,496	198,715	185,054	198,870	182,503	185,999	173,954	174,517	166,583	164,205	150,178
Operating expenses:
Selling, general and administrative
172,441	171,422	167,440	171,599	164,529	161,579	147,303	156,811	147,893	151,816	143,849	147,946	137,864	139,307	128,851	135,842	122,901	118,219	111,095	129,251	116,336	122,520	110,520	122,242	115,101	111,748	101,323	115,056	109,628	107,815	98,303	105,908	101,958	100,552	94,203	103,328	92,549	91,581	84,791	83,875	84,133	84,094	76,756
Research and development
51,449	49,943	48,033	51,139	47,610	43,111	38,791	39,657	37,434	40,643	37,415	36,701	35,130	38,190	34,446	34,380	28,109	28,970	27,192	28,523	27,024	29,294	30,024	31,796	29,530	29,537	27,363	31,389	31,189	30,326	27,220	27,911	28,398	27,218	26,206	26,977	23,319	21,972	19,739	19,950	18,279	19,059	17,914
Amortization of acquired intangible assets
8,272	12,052	18,480	43,576	10,940	9,199	12,867	11,610	11,673	11,317	11,783	11,769	11,378	11,690	11,741	12,629	4,558	4,429	2,307	2,109	2,203	2,262	2,094	2,408	2,459	2,454	2,412	2,472	2,533	2,501	2,636	2,920	3,592	3,691	3,771	2,870	2,673	2,573	2,030	2,074	1,992	2,130	1,845
Restructuring expenses (note 22)
-	-	-	-	-	-	-	-	10,922	-	-	-	7,945	4,413	-	-	0	6,914	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Litigation settlement expenses
-	-600	-	-	-	-	-	-	-	-	-	-	-	8,500	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition related expenses
-	-	-	-	-	6,123	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
232,162	229,321	233,953	316,914	223,993	217,454	198,961	215,588	207,922	203,776	193,047	196,416	192,317	212,176	175,038	182,851	155,568	158,532	140,594	159,883	145,563	154,076	142,638	162,772	147,090	143,739	131,098	173,682	143,350	140,642	128,159	136,739	133,948	131,461	124,180	132,175	118,541	116,126	107,560	105,899	105,404	106,283	97,515
Income from operations
217,500	197,809	171,102	121,076	156,977	157,078	144,132	146,884	136,373	146,016	112,558	127,360	107,397	96,895	94,146	118,638	104,312	107,977	98,025	99,547	105,868	109,146	94,675	98,485	104,698	105,020	96,884	86,166	96,099	92,070	80,489	89,731	76,548	67,254	60,874	66,695	63,962	69,873	66,394	68,618	61,179	57,922	52,663
Other income (loss), net:
Interest income
116	202	449	284	415	678	922	2,701	4,228	4,579	4,870	4,561	4,425	4,191	3,908	8,831	2,131	2,476	3,422	10,445	4,761	5,418	5,584	12,055	6,015	6,752	6,414	13,826	8,078	8,498	8,471	12,111	7,650	7,181	6,924	10,036	6,663	6,005	5,097	7,313	4,092	3,166	2,125
Interest expense
9,968	10,220	10,992	12,548	12,413	7,487	3,708	5,481	7,719	7,370	7,785	7,871	7,336	6,628	6,401	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss attributable to equity method investments (note 5)
-5,295	-6,924	-6,863	-	-5,996	-3,375	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other, net
-10,698	-2,115	-3,109	-6,586	-1,054	-621	-2,465	-3,185	-2,739	-1,460	-1,158	-2,429	3,504	1,749	1,272	1,168	2,553	3,242	-2,003	-97	3,729	947	1,671	2,224	2,199	-2,311	-1,228	-5,779	3,815	-2,168	1,941	1,454	-191	8,496	-1,301	2,236	398	3,043	5,063	-1,336	2,387	2,009	3,118
Total other income (loss), net
-25,845	-19,057	-20,515	-25,312	-19,048	-10,805	-5,251	-5,965	-6,230	-4,251	-4,073	-5,739	593	-688	-1,221	-1,207	4,684	5,718	1,419	4,570	8,490	6,365	7,255	8,150	8,214	4,441	5,186	1,660	11,893	6,330	10,412	8,779	7,459	15,677	5,623	10,514	7,061	9,048	10,160	3,310	6,479	5,175	5,243
Income before income taxes
191,655	178,752	150,587	95,764	137,929	146,273	138,881	140,919	130,143	141,765	108,485	121,621	107,990	96,207	92,925	117,431	108,996	113,695	99,444	104,117	114,358	115,511	101,930	106,635	112,912	109,461	102,070	87,826	107,992	98,400	90,901	98,510	84,007	82,931	66,497	77,209	71,023	78,921	76,554	71,928	67,658	63,097	57,906
Income taxes
28,518	18,198	30,439	26,964	32,513	21,634	33,144	31,108	20,018	132,238	22,360	20,010	20,167	19,464	16,818	34,306	18,205	18,119	16,527	16,655	23,375	24,330	18,670	18,897	22,943	22,825	21,140	14,813	23,079	20,458	19,636	21,663	19,394	20,059	15,979	18,737	17,673	20,465	19,846	18,762	18,824	17,114	15,804
Net income
163,137	160,554	120,148	68,800	105,416	124,639	105,737	109,811	110,125	9,527	86,125	101,611	87,823	76,743	76,107	83,125	90,791	95,576	82,917	87,462	90,983	91,181	83,260	87,738	89,969	86,636	80,930	73,013	84,913	77,942	71,265	76,847	64,613	62,872	50,518	58,472	53,350	58,456	56,708	53,166	48,834	45,983	42,102
Basic earnings per share (note 11)
1.13	1.11	0.84	0.48	0.74	0.87	0.74	0.76	0.77	0.07	0.61	0.72	0.62	0.54	0.54	0.59	0.65	0.68	0.59	0.62	0.65	0.65	0.59	0.62	0.64	0.61	0.57	0.52	0.59	0.54	0.50	0.53	0.45	0.43	0.34	0.39	0.35	0.38	0.37	0.35	0.32	0.31	0.28
Diluted earnings per share (note 11)
1.12	1.10	0.83	0.48	0.73	0.86	0.73	0.76	0.76	0.07	0.60	0.70	0.62	0.54	0.54	0.59	0.64	0.68	0.58	0.61	0.64	0.64	0.58	0.60	0.63	0.60	0.56	0.50	0.58	0.53	0.49	0.52	0.44	0.42	0.33	0.37	0.34	0.37	0.36	0.35	0.31	0.30	0.27
Dividend declared per share
0.39	0.39	0.39	0.37	0.37	0.37	0.37	0.35	0.35	0.35	0.35	0.33	0.33	0.33	0.33	0.30	0.30	0.30	0.30	0.28	0.28	0.28	0.28	0.25	0.25	0.25	0.25	0.17	0.17	0.17	0.17	-	-	-	-	-	-	-	-	-	-	-	-
Basic shares outstanding (000's)
144,638	144,212	143,719	143,537	143,316	142,923	142,668	143,196	142,898	142,715	142,247	141,631	141,714	141,310	140,785	140,546	140,187	139,926	140,309	140,905	140,792	140,048	140,127	140,730	140,959	142,202	142,005	142,658	143,293	143,214	142,651	142,845	144,024	146,369	150,366	152,739	153,251	152,420	151,474	302,447	150	150,246	150,788
Diluted shares outstanding (000's)
145,680	145,575	145,099	145,224	144,333	144,349	144,030	144,628	143,985	143,855	143,480	142,901	142,724	142,097	142,090	141,741	141,232	141,423	142,280	143,050	142,813	142,202	142,683	143,270	143,375	145,335	145,456	146,253	146,643	146,689	146,055	146,541	147,157	149,515	154,051	156,819	157,616	157,593	156,752	312,644	155	154,068	153,524